ZORYVE
ZORYVE
Approved
DIN Number
02556146
Drug Class
Human
Market Date
Mar 18, 2025
Company
HC
arcutis canada, inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02556146
AIG Number0152826003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D05AX06 ROFLUMILAST
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification84:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ROFLUMILASTActive
Strength: 0.15 % / W/W
Monograph: ROFLUMILAST